HCA

Healthcare

HCA Healthcare

Price Chart

Market Data

Financials

XBRL · SEC EDGAR

2016–2025(10yr)

Revenue

Net Income

Free CF

Metric	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025Latest	YoY
Revenue	$41.5B	$43.6B	$46.7B	$51.3B	$51.5B	$58.8B	$60.2B	$65.0B	$70.6B	$75.6B	+7.1%
Net Income	$2.9B	$2.2B	$3.8B	$3.5B	$3.8B	$7.0B	$5.6B	$5.2B	$5.8B	$6.8B	+17.8%
Net Margin	7.0%	5.1%	8.1%	6.8%	7.3%	11.8%	9.4%	8.1%	8.2%	9.0%	+0.8pp
Free Cash Flow	$2.9B	$2.4B	$3.2B	$3.4B	$6.4B	$5.4B	$4.1B	$4.7B	$5.6B	$7.7B	+36.4%
FCF Margin	7.0%	5.5%	6.8%	6.7%	12.4%	9.2%	6.9%	7.2%	8.0%	10.2%	+2.2pp
EPS (Diluted)	$7.30	$5.95	$10.66	$10.07	$10.93	$21.16	$19.15	$18.97	$22.00	$28.33	+28.8%

Total Debt$44.3B

Cash & Equiv.$1.0B

Net Debt$43.2B

4 min read

1. THE BIG PICTURE

HCA Healthcare is an efficiency machine that prioritizes margin and cash flow over raw top-line expansion. While it grows more slowly than diversified peers like UnitedHealth or McKesson, HCA maintains a sector-leading 16.3% operating margin by dominating high-acuity care within concentrated local networks (Peer Benchmarking). This strategy allows HCA Healthcare to generate 12.4 cents of free cash flow from every dollar of revenue—the highest in its peer group—which it uses to aggressively repurchase shares and offset modest volume growth (Peer Benchmarking).

2. WHERE THE RISKS HIT HARDEST

HCA’s core strength of "comprehensive local health care networks" is simultaneously its greatest vulnerability. HCA Healthcare’s reliance on Florida and Texas for 51% of consolidated revenues means that any regional regulatory shift or natural disaster in those two states directly threatens more than half of its business (Risks). Furthermore, HCA’s focus on "operational excellence" and AI-driven efficiency is capital-intensive; however, its $46.492 billion debt load limits the cash available for these critical technology investments and increases its vulnerability to interest rate fluctuations (Risks). Finally, the industry-leading 8.4% net margin is highly sensitive to labor markets; shortages of nurses and healthcare professionals are forcing HCA to rely on expensive temporary contract personnel, which threatens to compress those margins (Risks).

3. WHAT THE NUMBERS SAY TOGETHER

The financial data reveals a company that is successfully manufacturing earnings growth through financial engineering and efficiency rather than rapid patient expansion. While fourth-quarter 2025 revenue grew 6.7%, same-facility inpatient surgeries were flat and outpatient surgeries actually declined by 0.5% (8-K). Despite these stagnant volumes, net income attributable to HCA rose 30.6% in the same period, driven by a 2.9% increase in revenue per equivalent admission and disciplined cost management (8-K). HCA’s 12.4% FCFFCFFree Cash Flow — cash left after paying for operations and capital investments; what the company can actually spend, save, or return to shareholders margin is nearly double the 6.6% of UnitedHealth, providing the capital for a 7.8% buyback yield—the highest among its peers (Peer Benchmarking). This suggests that even as the "operating environment" remains only "mostly stable," HCA can continue to deliver per-share growth by retiring its own stock (8-K).

4. IS IT WORTH IT AT THIS PRICE?

At 16.2x Forward P/EP/EPrice-to-Earnings ratio — share price divided by annual earnings per share; how much investors pay per dollar of profit. Higher P/E = higher growth expectations, HCA trades at a 14% premium to the peer median of 14.2x (Peer Benchmarking). According to the (CAPM analysis), the market is currently pricing in ~5.7% long-term growth. This premium is supported by HCA’s status as the peer leader in both net margin (8.4%) and FCFFCFFree Cash Flow — cash left after paying for operations and capital investments; what the company can actually spend, save, or return to shareholders margin (12.4%), which suggests it is a higher-quality earner than peers like CVS, which reported a negative net margin (Peer Benchmarking). However, the valuation is sensitive to any slowdown; if growth targets fall to 5.0%, the justified multiple would drop to 14.5x (CAPM analysis). The primary factor that could force a de-rating is HCA’s 4.9x net leverage—$45.1 billion in net debt is a significant burden that makes the stock more volatile than its lower-debt peers (Peer Benchmarking).

5. WHAT WOULD CHANGE THIS VIEW?

Cautious if same-facility outpatient surgeries continue to decline (down 0.5% in Q4 2025), as this suggests a structural shift of high-margin procedures away from HCA facilities (8-K).
Constructive if the implementation of the new EHR platform and "Timpani" staffing tools results in a measurable decrease in the use of expensive contract labor (Risks).
Cautious if legislative changes occur regarding "site-neutral payment policies," which would directly hit the 45.4% of revenue HCA derives from government programs (Risks).

6. BOTTOM LINE

Structural Advantage: Massive regional scale and proprietary staffing technology that produce industry-leading cash flow conversion and operating margins.

Bottom Line: HCA is a high-performance operator that justifies its premium valuation through aggressive share buybacks, though its heavy debt and geographic concentration make it a higher-risk play than its diversified peers.

Source: Synthesis · LLM Analysis

3 min read

1. Top 5 Material Risks

Indebtedness: HCA Healthcare carries $46.492 billion in total debt, which limits the ability to fund operations, share repurchases, and acquisitions, while increasing vulnerability to interest rate fluctuations and economic downturns.
Geographic Concentration: With 102 of its 190 hospitals located in Florida and Texas, these two states account for 51% of consolidated revenues, creating high sensitivity to local regulatory changes, natural disasters, and economic shifts.
Government Reimbursement: Medicare and Medicaid provided 45.4% of 2025 revenues; statutory or regulatory changes to these programs, such as sequestration or site-neutral payment policies, directly threaten reimbursement levels.
Workforce Competition: Shortages of nurses and other health care professionals, exacerbated by burnout and inflationary pressure, force HCA Healthcare to increase wages and rely on expensive temporary contract personnel, which can compress operating margins.
Cybersecurity and Information Systems: As a heavy user of electronic health records (EHR) and internet-connected medical devices, HCA Healthcare faces risks of ransomware, data breaches, and system failures that could impair billing, clinical care, and financial reporting.

2. Company-Specific Risks

Physician Recruitment: HCA Healthcare faces increasing competition to retain quality physicians who often hold admitting privileges at competing hospitals, and HCA Healthcare’s performance is tied to the admission and utilization practices of these non-employee physicians.
EHR Implementation: The ongoing, complex, and time-intensive transition to a new EHR platform across facilities requires significant internal resources and risks operational disruptions or excessive costs that could divert management attention from strategic priorities.
Ownership Influence: Certain Frist-affiliated investors hold approximately 31% of outstanding common stock and retain the right to nominate members to the Board of Directors, potentially influencing corporate transactions and preventing changes in board composition.
Insurance Subsidiary Exposure: HCA Healthcare’s insurance subsidiary holds $588 million in investment securities, which are subject to market risk, potential credit-related impairments, and liquidity constraints if cash is needed on short notice to pay claims.

3. Regulatory/Legal Risks

Anti-kickback and Stark Law: HCA Healthcare maintains complex financial relationships with physicians that must comply with federal Anti-kickback and Stark Law requirements; failure to meet safe harbors or exceptions could lead to civil or criminal penalties and exclusion from federal programs.
False Claims Act (FCA): HCA Healthcare is subject to potential qui tam or "whistleblower" suits alleging the submission of false claims for payment, which can result in significant liability and government investigations.
Price Transparency: Compliance with the No Surprises Act and other transparency mandates requires publishing standard charges and good faith estimates; failure to comply or perceptions that HCA Healthcare’s charges are higher than competitors could negatively impact patient volume and payer negotiations.
Environmental Regulations: Operations generate medical waste requiring strict disposal compliance; failure to adhere to these standards could result in significant investigation and clean-up costs.

4. Financial Impact Map

Indebtedness → Cash Flows from Operations → Requires dedication of cash to principal and interest payments, reducing funds for capital expenditures. Geographic Concentration → Consolidated Revenues → 51% of total revenue is derived from Florida and Texas, making the top-line highly sensitive to regional shocks. Government Reimbursement → Revenues → 45.4% of total revenue is derived from Medicare and Medicaid, directly linking reimbursement rates to federal and state policy. Workforce Competition → Operating Expenses → Increased wages and reliance on temporary contract personnel directly inflate labor costs. Uncompensated Care → Accounts Receivable → $7.674 billion in estimated implicit price concessions recorded as of December 31, 2025, to adjust for uncollectible accounts.

Source: 10-K Item 1A · LLM Analysis

Recent Filings

Form	Filed	Period
10-K	Feb 2026	Dec 2025
8-K	Jan 2026	—
10-Q	Oct 2025	Sep 2025
14A	Mar 2025	—